Overview

A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee

Status:
Completed
Trial end date:
2009-12-25
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the safety and tolerability of single IV doses of PF-04383119 in Japanese patients with moderate to severe pain from OA of the knee (Part I). To evaluate the preliminary analgesic efficacy of PF-04383119 in Japanese patients with moderate to severe pain from OA of the knee in comparison with placebo (Part I and Part II).
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Treatments:
Tanezumab
Criteria
Inclusion Criteria:

- Japanese Male or female, Age 35-65 (Part 1), Age 35-75 (Part 2)

- Diagnosis of osteoarthritis (OA) of the knee based on American College of Rheumatology
criteria

- Knee pain, and radiographic evidence of knee OA (Kellgren-Lawrence x-ray grade ≥2)
obtained within 1 year of enrollment

- At least one of the following: age >50, morning stiffness <30 minutes in duration,
crepitus, and OA of the knee must involve the index tibiofemoral joint and must have
present for at least 6 months

- Patients who meet at least one of the following: unwilling to take non-opiate pain
medications, or for whom non-opiate pain medications have failed, or are candidates
for or seeking invasive interventions such as intraarticular injections, knee
arthroplasty, or total knee surgery

- Pain levels as required by the protocol at Screening and Baseline

Exclusion Criteria:

- Diagnosis or history of RA, any inflammatory arthritis, gout, Paget's disease or any
other disease that in the Investigator's opinion would interfere with the assessment
of pain and other symptoms of OA

- Patients with regional pain syndromes suggestive of fibromyalgia or regional pain
caused by lumbar or cervical compressions with radiculopathy or at risk of developing
radiculopathy.

- Diagnosis or history of fibromyalgia

- Planned surgical procedure during the duration of the study